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a b s t r a c t
Alpha-lipoic acid (ALA) immobilized polysulfone (PSF) hemodialysis membranes have been fabricated by
the dry–wet phase inversion technique. The antioxidant properties of the membranes were evaluated in
terms of inhibition of reactive oxygen species (ROS) in blood plasma, while their blood compatibilities
were determined by quantitating plasma protein adsorption, platelet adhesion, activation and cytotoxi-
city to blood cells. The stability of ALA under typical hemodialysis conditions was improved by
immobilization, and the greatest enhancement was achieved when it was sandwiched between two
polyethyleneimine (PEI) layers. In vitro antioxidant activity measurements showed that ALA coated
membranes are not only capable of reducing ROS levels in blood, protein adsorption and platelet
activation on the membranes, but, can also prolong coagulation time. All membranes prepared were
noncytotoxic to peripheral blood mononuclear cells. In addition, the high permeation rates of solutes
through PSF membrane were not affected by ALA immobilization.
& 2013 Elsevier B.V. All rights reserved.
1. Introduction
During hemodialysis significant amount of reactive oxygen
species is generated due to leukocyte activation [1]. These free
radicals react with the proteins and lipids in blood causing
oxidative stress which acts in forming three important problems
– cardiovascular disease, cancer, and age-associated neurodegen-
erative diseases [2]. The potential cause of oxidative stress is the
reduction of antioxidant defence in uremic patients. As a result,
antioxidants are administrated to hemodialysis patients orally or
intravenously [3–4]. Over the last 10 years, researchers focused on
developing functional hemodialysis membranes to suppress
hemodialysis-induced oxidative stress. The most commonly used
approach is to immobilize antioxidants, vitamin E and linoleic
acid, onto these membranes [5–11]. Mydlik et al. compared the
effectiveness of oral vitamin E intake against the use of a vitamin E
coated synthetic hemodialysis membranes on oxidative stress
levels in blood [5]. They reported that vitamin E coated dialyzer
provided more effective antioxidant defense than peroral admin-
istration of vitamin E in hemodialysis patients. Yamamoto et al.
observed that vitamin C administration increased antioxidant
activity of the vitamin-E coated membrane [7]. Kung and Yang
covalently attached conjugated linoleic acid (CLA) onto industrial
hemodialysis membranes manufactured from cellulose acetate,
polyacrylonitrile and polysulfone. CLA immobilization not only
inhibited production of ROS but also reduced platelet adhesion,
protein adsorption and prolonged blood coagulation time [8–11].
Recently, Neelakandan et al. modified poly(amide):poly(vinyl
pyrrolidone) membranes with a soybean-derived phytochemical,
genistein [12]. The modified membranes showed significant sup-
pression of three clinically relevant cytokines and exhibited a dose
dependent suppression of ROS levels in blood.
Unlike other antioxidants, alpha-lipoic acid (ALA) and its
reduced form dihydrolipoic acid (DHLA) effectively quench a
number of free radicals in both lipid and aqueous media, ALA
and DHLA together have metal-chelating activity and which may
have effects on regulatory proteins and on genes involved in
normal growth and metabolism [13]. Therefore, ALA is widely
used as a drug for prevention of various chronic diseases asso-
ciated with oxidative stress, and is administered as a daily
supplement for dietary purposes, antiageing, diabetes, and cardi-
ovascular disease. In recent years, some clinical studies showed
that administration of ALA therapy could decrease the biomarkers
of oxidative stress in end-stage renal disease patients under
hemodialysis [14] and prolong clotting time via inhibition of an
intrinsic coagulation pathway [15–16]. However, instability of ALA
under light or heat and its short biological half-life (30 min), may
restrict its effective medical usage [17–18]. To increase its stability
and provide controlled delivery, ALA was encapsulated into
chitosan [17,19] and chitosan-alginate complexes [18]. In addition,
microcrystalline cellulose and poly(vinylidine fluoride)/cellulose
ester blend membranes were functionalized with ALA and showed
an excellent long-term antioxidant activity [20–21].
In this study, ALA was selected as the antioxidant to modify
polysulfone (PSF) based hemodialysis membranes. The source of
motivation for the present work is a need for functional hemodialysis
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membranes that are capable of suppressing oxidative stress.
In addition, few have utilized the unique antioxidant properties of
ALA. The PSF membranes were prepared by dry/wet phase inversion
method and modified with ALA through an intermediate polyethy-
leneimine (PEI) layer. The antioxidant activities of free and immobi-
lized ALAwere measured using the free-radical scavenging activity of
2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals. The blood compat-
ibilities of the membranes were evaluated in terms of inhibition of
reactive oxygen species in blood plasma, amount of adsorbed plasma
proteins, platelet adhesion, activation and cytotoxicity on blood cells.
The transport and structural properties of the membranes were also
characterized. To the best of our knowledge, this is the first study
that suggests immobilization of ALA onto hemodialysis membranes
to prevent hemodialysis induced oxidative stress. Furthermore, the
immobilization method used in this study is unique in that anti-
oxidants are not attached on the membranes covalently through a
complex chemistry. Our method is based on adsorbing positively
charged, hydrophilic polyelectrolyte PEI on the negatively charged
membrane surface and then site-specifically binding a carboxylic
group of ALA to an ammonium group of PEI through electrostatic
interactions. Thus, the cyclic disulfide bond that forms the active site
of ALA becomes available on the surface of the membrane to
scavenge ROS.
2. Materials and methods
2.1. Materials
PSF with a molecular weight of 26,000 g mol1, 1-2 dichlor-
oethane, chlorosulfonic acid, sodium dodecylsulfate (SDS) were
purchased from Aldrich, 1-methyl-2-pyrrolidone (NMP) with a
purity of ⪢98% and micro BCA protein assay reagent kit were
purchased from Fluka and Thermoscientific, respectively. Bovine
serum albumin (MW 65,000), urea, vitamin B12, lysozyme, poly-
ethyleneimine (pKa:8.8), 2,2-diphenyl-1-picrylhydrazyl and alpha-
lipoic acid were all supplied by Sigma. Cell viability kits, thiazole
orange (TO) and propidium iodide (PI), and the monoclonal
antibodies, PAC1, FITC and CD62 PE, used for determining platelet
activation were purchased from Becton Dickinson Immunocyto-
metry Systems. H2NaPO4 and Na2HPO4 used for preparing buffer
solutions were obtained from Fluka and Riedel, respectively. Water
used in the experiments was distilled ion-exchanged water.
2.2. Preparation of the membranes
The conventional PSF was first modified by sulfonation to
induce negatively charged groups (SO3) before preparing the
support membrane. For this purpose, PSF was dissolved in dichlor-
oethane (DCE) to obtain a 7.5 wt% solution. Similarly, a solution of
chlorosulfonic acid diluted in DCE (10 wt%) was prepared and
added drop-wise to the PSF solution. After mixing for 3 h at 24 1C,
modified polymer was recovered by precipitation in 50 mL of
methanol. Ion exchange capacity (IEC) of sulfonated PSF (SPSF)
was determined as 0.9 meq. g1.
To prepare the PSF and PSF–SPSF blend membranes, a solution
of 20 wt% of PSF or 10 wt% of PSF and 10 wt% of SPSF in N-methyl
pyrrolidone was cast onto a 10 cm24 cm glass substrate, respec-
tively with the aid of an automatic film applicator (Sheen Instru-
ment Ltd., model number: 1133N) at a speed of 100 mm s1.
The initial thickness of the cast film was adjusted by a four-sided
applicator with a gap size of 150 μm. Following casting, the
support was transferred into an environmental chamber (Ange-
lantoni Industrie, Italy, Challenge Series, model number: CH250) in
which the solution was dried for 2 min at 25 1C and 40% relative
humidity. Then, it was immediately immersed in a coagulation
bath for 18 h, and rinsed with pure water for 1 h. The membranes
were allowed to dry further for a period of 72 h in a vacuum oven
maintained at 100 1C. They were then kept in a desiccator until
their use.
The method used for immobilizing ALA is based on initially
adsorbing positively charged, hydrophilic polyelectrolyte, PEI, on the
negatively charged membrane surface. For this purpose, the PSF–SPSF
membrane was dipped in a 1mgmL1 of PEI solution for 10 min.
The pH of the PEI solution was adjusted to a value of 8 by HCl, to
obtain a sufficiently protonated form, ensuring a strong bonding on
the negatively charged membrane surface through electrostatic attrac-
tion. To remove excessive PEI on the surface, the membrane was
rinsed with 500 mL water for 10 min and then immersed in a
1 mgmL1 or 5 mgmL1 of ALA solution in 5 vol% ethanol in PBS
(pH:7.4) for 30 min at room temperature. The amount of ALA adsorbed
on the membrane (mg) was determined from the difference between
the initial amount in the solution before contacting with the mem-
brane and that after 30 min of contact. The adsorbed amount was
divided to the surface area of the membrane to give the interfacial
concentration (mg/cm2). The concentration of ALA in the solution
was measured using a UV spectrophotometer (Perkin Elmer Model
No: Lambda 45) at 333 nm. Fig. 1 shows the site-specific binding of the
carboxylic group of ALA to the ammonium group of PEI through
electrostatic interactions. This method allows the cyclic disulfide bond,
which forms the active site of ALA, to become free on the surface of
the membrane.
2.3. Measurement of antioxidant activity
Alpha-lipoic acid and its reduced metabolite, dihydrolipoic acid
(DHLA) (Fig. 2), form a redox couple and may scavenge a wide
range of reactive oxygen species such as hydroxyl radicals, nitric
oxide radicals, peroxynitrite, hydrogen peroxide and hypochlorite.
The antioxidant activity of ALA was measured using the free-
radical scavenging activity of DPPH radicals.
Fig. 1. Structures of PEI and ALA and their possible ionic complexation
Fig. 2. Chemical structure of alpha-lipoic acid (ALA) and dihydrolipoic acid (DHLA).
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To measure free and immobilized antioxidant activities, ALA
solutions freshly prepared in absolute ethanol were mixed with
0.1 mM ethanolic DPPH in a cuvette or the membranes were
immersed into 3 mL of 0.1 mM ethanolic DPPH, respectively. As
the odd electron of DPPH becomes paired off, the absorption
vanishes and resulting decolorization is stoichiometric with
respect to the number of electrons taken up. Radical scavenging
activity (RSA) was then determined by measuring the decrease in
the absorption of DPPH solution at 516 nm as follows:
RSA%¼ Absorbance0Absorbanceeqb
Absorbance0
 
100 ð1Þ
where Absorbance0 and Absorbanceeqb represent absorbance mea-
sured at the beginning and at equilibrium, respectively.
To determine stability of immobilized ALA under typical hemo-
dialysis conditions, 4 cm2 of membranes were immersed into
10 mL of 0.05 M phosphate buffer solution at pH 7.4 and 37 1C.
The solution was stirred thoroughly and the membrane samples
were removed from the solution after 4 and 24 h. Then, the
activity of the immobilized ALA and amount of released ALA were
determined spectrophotometrically. To simulate blood flow under
typical hemodialysis conditions, a dead-end ultrafiltration cell was
used. 0.05 M phosphate buffer solution at pH 7.4 was filtered
during 4 h at 200 mL min1 flowrate and amount of ALA lost from
the membranes was analyzed by UV-spectrophotometer. Further-
more, the membranes were treated with ethyleneoxide gas at
54 1C for 16 h and then incubated in laminar air flow cabinet for
24 h in order to remove the ethyleneoxide from the membranes.
Finally, their radical scavenging activities were measured.
2.4. Protein adsorption experiments
Protein adsorption experiments were performed with 50%
platelet poor plasma (PPP) obtained from fresh blood (collected
with citrated tubes from healthy volunteers) by centrifugation at
2800 rpm for 15 min at room temperature. The membranes
(1.5 cm1.5 cm) equilibrated in 0.05 M, pH 7.4 phosphate buffer
at 37 1C for 15 h, were first placed onto a 24-well plate and 1.0 mL
of PPP was poured onto them. After incubating with PPP for 1 h at
37 1C, the membranes were rinsed three times with PBS, removed
from the well plate, and rinsed again for 10 min with 50 mL of PBS
in order to remove loosely-bond protein. Each membrane sample
was placed into a glass bottle containing 1 wt% aqueous solution of
sodium dodecylsulfate (SDS) and shaken (150 rpm) in a shaking
bath for 1 h at room temperature to detach the adsorbed protein
on the surface. In order to take into account an interference which
may be caused by SDS, membrane samples not treated with
protein was used as a proper control. A protein analysis kit (Micro
BCA protein assay reagent kit, #23235, Pierce, Rockford, IL, USA)
based on the bicinchoninic acid (BCA) method was used to
determine the protein concentration in the SDS solution. The
absorbance of the solution at 562 nm was measured by a spectro-
photometer (Perkin Elmer Model No: Lambda 45).
2.5. Measurement of ROS levels in plasma
Chemiluminescence (CL) method was used to measure the
production of ROS in the samples using a chemiluminescence
analyzer. Heparinized blood samples collected from healthy, non-
smoking donor were wrapped with aluminum foil to prevent light
exposure until testing for ROS levels. 2 mL whole blood was
incubated both with 2 cm2 modified and unmodified membranes
for 4 h at 37 1C. Then, 50 mL of blood sample was immediately placed
in a 96-well plate, an aliquot of 125 ml of luminol was added to the
blood sample and after 5 min incubation, 50 ml of HOCl was added.
Luminol (1 mg mL1) was used as an amplifier. The photon emission
from the sample was counted at 20-s intervals at room temperature
under atmospheric conditions. For each sample, the assay was
performed in triplicate, and the ROS levels were expressed as CL
counts.
2.6. Platelet adhesion and activation
In order to analyze the platelet activation, unmodified and
modified PSF membranes were incubated with acid citrate dex-
trose (ACD)-whole blood at 37 1C for 25 min. 5 mL of whole blood
suspension was carefully placed into the tubes and monoclonal
antibodies, PAC1, FITC and CD62 PE, were then added. Specificity of
PAC1 binding is demonstrated by staining in the presence of RGDS
peptide (a competitive inhibitor) as the negative control tube.
Without vortex mixing, the tubes were gently mixed and incu-
bated in the dark for 15–20 min at room temperature. Following
the incubation period, 1 mL of cold 1 wt% paraformaldehyde was
added to each tube and stored at 2–8 1C in the dark for at least 2 h.
Finally, the percentage of activated platelets was counted by Flow
Cytometer (BD FacsCanto).
The morphology of adhered platelets on the modified and
unmodified PSF membrane surfaces was determined by incubating
the samples with platelet rich plasma (PRP) for 25 min at 37 1C.
After incubation, the samples were gently washed to remove
unbound platelets, fixed with glutaraldehyde (2.5 vol% in 0.1 M
sodium cacodylate buffer, pH 7.2) for 30 min at 4 1C, and rinsed
three times with PBS buffer (0.1 M, pH 7.4). The samples were then
dehydrated in graded ethanol series (30, 50, 70, 90, and 100 vol%,
500 mL each) for 10 min each and air-dried. Lastly, they were
sputtered with gold and analyzed with SEM (FEI-Quanta 250 FEG).
2.7. Cell viability assay
To determine toxic effects of the membranes, peripheral blood
mononuclear cells (PBMCs) were isolated from the sample of
healthy human blood by using ficol hypec gradient centrifugation.
The membranes (1.5 cm1.5 cm) were placed in 96 well plates
with 200 μL PBMCs sample and maintained at 37 1C for 4 h.
The number of live and dead cells labeled with Thiazole Orange
(TO) and Propidium Iodide (PI), respectively, was determined with
Flow cytometer (BD FacsCanto) [12].
2.8. Blood coagulation time
Blood coagulation time was measured by activated partial
thromboplastin time (APTT). The sample membrane (11 cm2)
was put in a glass tube, 100 μL of actin activated cephaloplastin
reagent (Dade Behring Inc., USA) was added, and the tube was
incubated at 37 1C for 1 min. Then, 100 μL of PPP was added to the
sample solution at 37 1C, incubated for 3 min, and finally 100 μL of
0.025 M CaCl2 solution was added. The clotting time of the plasma
solution was recorded at the first sign of fibrin formation.
2.9. Permeation experiments
Permeation experiments were carried out in a side-by-side
diffusion cell (Permegear Membrane Transport Systems). The
membrane with an area of 1.5 cm2 was placed between two
chambers, each with a volume of 6 mL. The left-side (donor)
chamber was filled with phosphate buffer (pH 7.4) containing
desired amount of solute (urea, vitamin B12, lysozyme) while the
right-side (receiver) chamber was only filled with phosphate
buffer (pH 7.4). The solution in each chamber was stirred suffi-
ciently to eliminate a concentration gradient and the temperature
was maintained constant at 37 1C by circulating water through the
jacket which surrounds the chambers. Samples were removed
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from each chamber at given time intervals and the concentration
of lysozyme and vitamin B12 was determined by directly measur-
ing their natural absorbance at 280 and 360 nm, respectively.
The concentration of urea was determined using commercial
enzymatic kits (BT Product, Turkey). 1/100 sample/reagent ratio
was used to detect the urea concentration. Samples were added to
1 mL of reagent, allowed to react and the concentration of urea
was determined from the difference in absorbance readings at
340 nm taken exactly after 30 and 90 s.
The overall mass transfer coefficient, k0, was evaluated directly
from the solute concentration data using the integrated form of
the solute mass balance [22]:
ln
C1ðtf ÞC2ðtf Þ
C1ðt0ÞC2ðt0Þ
 
¼ k0  A
1
V1
 1
V2
 
ðtft0Þ ð2Þ
where A is the area of the membrane, V1 and V2 are the volumes of
the chambers, and C1 and C2 are the concentrations at times t0 and
tf, respectively. The overall mass transfer coefficient (k0) has
contributions both from the bulk fluid and the membrane:
1
k0
¼ 1
Pm
þ 2
kb
ð3Þ
Pm and kb in Eq. (3) correspond to the permeability and the bulk
mass transfer coefficient of the solute, respectively, while the factor
of two in the second term of the right-hand side of this equation
reflects the presence of boundary layers in the two chambers. The
bulk mass transfer coefficient was evaluated from Eq. (4) with
α¼0.27 based on the specific geometry of the diffusion cell [22]:
kbr
D1
¼ α  Re0:567  Sc0:33 ð4Þ
where r is the radius of the cell and D1 is the diffusivity of the
solutes in the solution. The effective permeation coefficients of the
solutes were then determined from Eq. (3).
2.10. Surface characterization studies
Contact angle measurements for distilled water were carried
out with Attension optical tensiometer by means of a horizontal
microscope, equipped with a video camera connected to a com-
puter. The volume of liquid drop varied between 3 and 5 μL. The
contact angle was calculated from the droplet screen image. Each
reported contact angle measurement represents an average value
of five separate drops on different areas of the membranes.
The XPS data were acquired with a X-ray Photoelectron
Spectrometer PHI-5000 Versaprobe using an Al-monochromatic
X-ray source (600 W). Survey spectra (0–1200 eV) were taken at a
constant analyzer pass energy of 187.85 eV, and binding energy
windows for C1s, N1s, O1s and S2p were obtained at a pass energy
of 93.90 eV. 1 cm1 cm sample was used and high-resolution
spectra of C1s, N1s, O1s and S2p peaks were recorded at the
takeoff angle of 451. In order to predict which components are
close to the surface, the takeoff angle between the film surface and
the photoelectron energy analyzer was adjusted at 151 and 751.
Each peak was deconvoluted by assuming a Gaussian distribution
and the area under the curve was calculated by using Microcal
Origin software.
To determine the surface roughness of the membranes, a
topographical map of the membrane surfaces was obtained with
Atomic Force Microscopy (AFM) on a Nanomagnetics Instrument
model. 3 mm3 mm surface was scanned with 512512 pixel
resolution using a silicon tip attached to a cantilever, while
maintaining a constant force between the tip and the sample.
2.11. Data analysis
All the measurements were carried out with at least 3 mem-
branes produced from three different batches. For each batch,
three experiments were run in parallel, thus, total of 9 measure-
ments were taken and the results were expressed as an average of
these 9 measurements7standart error. The data were analyzed
with the statistical software Minitab 15 using Student's paired t
test. The probability (p) values less than 0.05 (po0.05) were
considered to be statistically significant differences.
3. Result and discussion
This study aims to develop functional PSF membranes through α-
lipoic acid immobilization and investigate the in vitro effects of this
modification on blood compatibility of the membranes, especially on
the inhibition of reactive oxygen species in blood plasma. To achieve
this task, 2 uncoated (PSF and PSF–SPSF) and 3 coated membranes
(PEI–ALA-I, PEI–ALA-II, PEI–ALA-III) were prepared as listed in
Table 1. The coated membranes were manufactured by first adsorb-
ing a positively charged, hydrophilic polyelectrolyte PEI on the
negatively charged PSF–SPSF membrane surface and then binding
ALA to PEI through electrostatic interactions. In the case of PEI–ALA-II
membrane, ALA was sandwiched between two PEI layers, forming
the outermost layer of the PEI–ALA-I and PEI–ALA-III membranes.
3.1. Quantification of amount of ALA in membrane and release
of ALA from the membranes
It is crucial to determine the amount of ALA immobilized in the
membrane and the potential loss of ALA during typical hemodialysis
period. Fig. 3 shows that at low ALA concentration (1 mg mL1),
Table 1
Codes of the unmodified and modified PSF membranes.
Code of
membrane
Weight
percentages
(wt%)
Molecule type
on the last layer
ALA concentration
(mg mL1)
PSF SPSF NMP
PSF 20 0 80 – –
PSF–SPSF 10 10 80 – –
PEI–ALA-I 10 10 80 ALA 1
PEI–ALA-II 10 10 80 PEI 1
PEI–ALA-III 10 10 80 ALA 5
Fig. 3. Amount of immobilized and released ALA. Immobilized amount of ALA for
PEI–ALA-III membrane is statistically different than that of PEI–ALA-I and PEI–ALA-
II membranes (po0.05). Released amounts of ALA for each membrane are
statistically different from each other (po0.05).
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more than 50% of ALA added to the coating solution was retained in
the final membrane. Upon increase in ALA concentration in the
solution to 5 mgmL1, the ALA loading of the final membrane, PEI–
ALA-III, slightly increased compared with the amount immobilized in
PEI–ALA-I membrane.
The stabilities of membranes within 4 (typical hemodialysis
time) and 24 h were also demonstrated in Fig. 3. The statistical
analysis has shown that the amounts of ALA released from the
membranes at the end of 4 and 24 h are not significantly different
from each other (po0.05). As expected, the lowest amount of ALA
release occurred from the PEI–ALA-II membrane since ALA was
sandwiched between two PEI layers. Compared with this mem-
brane, the fraction of ALA leached out from the PEI–ALA-I and PEI–
ALA-III membranes relative to the amount immobilized into these
membranes initially is higher due to direct contact of ALA with the
solution. For all cases most of the loaded ALA retained within the
membranes after incubating with PBS for 4 and 24 h, implying a
sufficiently strong PEI–ALA complex formation. This results
because at pH 7.4 PEI is highly positively charged (pKa¼8.8) while
ALA is highly negatively charged (pKa¼5.2) [23] with degree of
ionization of 96% and 99%, respectively. The loss of ALA from the
membranes was determined not only at the static condition but
also under a 200 mL/min flowrate which is a typical value for
blood flow during hemodialysis. The loss from a 2 m2 area is
0.097 mg mL1 and 0.104 mg mL1 for no flow and flow condi-
tions, respectively. Both values are comparable to the amount
orally administered (0.100 mg mL1) to the patients in clinical
studies [14,24], thus, ALA released from the membranes does not
hinder their use in hemodialysis.
3.2. Surface characterization of PSF membranes
Fig. 4 shows that blending PSF with SPSF improved its hydro-
philic character as confirmed by the drop in the water contact
angle values. No significant decrease in the contact angle values
was observed through ALA immobilization on the surface of the
blend membrane due to presence of hydrophobic groups in
addition to hydrophilic groups in the structure of ALA. On the
other hand, the contact angle of the PEI–ALA-II membrane was
found significantly lower (po0.05) than that of the PSF–SPSF
blend membrane since hydrophilic polyelectrolyte PEI, forms the
last layer of this membrane.
XPS evaluation spectra of two different ALA coated PSF mem-
branes are shown in Fig. 5. In order to determine which component
is located close to the surface, the low angle (151) measurements
were performed and the ratio of the areas under the deconvoluted
peaks obtained with the PEI–ALA-I and PEI–ALA-II membranes
were calculated.
N1s high-resolution spectra, gives mainly charged amine group
nitrogen (–NH3þ) peak at 400.7 eV as shown in Fig. 5b. The peak
for uncharged amine group (–NH2) was not observed since 96% of
the amine groups of PEI are protonated. It is seen from Table 2 that
the area for N1s peak obtained at both 151 and 751 with PEI–ALA-II
membrane is higher than that for the PEI–ALA-I membrane. The
result at 151 simply indicates the presence of more –NH3þ groups
near the surface of the PEI–ALA-II membrane, hence, proving that
PEI forms the last layer of this membrane. The higher value of the
area at 751 for the PEI–ALA-II membrane results from the presence
of two PEI layers where ALA is sandwiched between these layers.
The S2p signal consists of three deconvoluted peaks (Fig. 5c).
The first peak situated at 162.7 eV, is the signal of the sulfur
bonded to carbon or hydrogen (–S–C or –S–H), the second peak
situated at 164.1 eV, is the signal of the elemental S (–S–S), and the
signal at higher binding energy (167.1 eV) represents the oxidized
sulfur species (–SO32 or –SO2). Larger area of the peak at 162.7 eV
and 164.1 eV, recorded at 151 for the PEI–ALA-I membrane
compared with the PEI–ALA-II (Table 2) confirms the presence of
ALA as the last layer of this membrane since nonoxidized S (–S–S,
–S–H or –S–C) exists only in the structure of ALA. This result also
confirms that the cyclic disulfide bond, the active site of ALA, is
available on the surface as proposed at the beginning of this study.
The ratio of the peak areas at 167.1 eV is close to 1 since these
peaks result from SO32 groups in the support membrane com-
mon to both PEI–ALA-I and PEI–ALA-II membranes.
The high-resolution C1s spectrum (Fig. 5d) shows four decon-
voluted peaks as follows: the aliphatic carbon (–C–C– or –C–H at
285.1 eV), carbon bonded to the amine groups (–HC–NR2, where R
is C or H, at 286.5 eV), the carboxyl carbon (–COO at 288.1 eV)
and carbon bonded to sulfur (–C–S– at 284.1 eV).
The O1s signal consists of two deconvoluted peaks (Fig. 5e).
The first peak situated at 532.4 eV represents the (SO32), and the
second peak situated at 530.4 eV represents the carboxylic oxygen
atom (COO).
The surface roughness of the membranes was obtained from
the analysis of AFM images shown in Fig. 6. The unmodified PSF
membrane had the smoothest surface with an average value of
74 nm while sulfonation significantly increased the surface rough-
ness to 242 nm. On the other hand, the layer by layer deposition of
PEI/ALA (103 nm) or PEI/ALA/PEI (98 nm) on the PSF–SPSF mem-
brane improved the smoothness of the surface. This can be
explained by the energy-minimization process taken place on
the surface of the support membrane where PEI undergoes
deformation to minimize the surface area as a result of enhanced
diffusional mobility of linear PEI chains.
3.3. The antioxidant activity of free α-lipoic acid and α-lipoic acid
immobilized membranes
The radical scavenging activities (RSA) of free and immobilized
ALA were calculated with Eq. (1) and the results are plotted in
Fig. 7. The initial antioxidant activities (10th minute) of free ALA
are higher than those of the immobilized ones due to increased
mass transfer resistance for the DPPH radical to reach active sites
of the ALA and limited accessibility to these sites. On the other
hand, at the end of 4 h, immobilized ALA has higher activities since
the antioxidant activity of free ALA is stable for only 10 min (data
not shown). Instability of ALA under light and heat and its short
biological half-life has also been reported by other studies [17–18].
The highest antioxidant activity was obtained with the PEI–ALA-I
membrane. This is not only due to the conserving activity of ALA
between two PEI layers, but also due to fewer ALA leached out
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from this membrane during 4 h. Although the initial antioxidant
activity of the PEI–ALA-III membrane is higher than that of the
PEI–ALA-I membrane due to higher ALA loading in this membrane,
their activities are almost the same at the end of 4 h. The results in
Fig. 7 indicate that ALA can maintain its antioxidant activity during
typical hemodialysis time by immobilizing onto the membrane,
especially between two hydrophilic polyelectrolyte layers.
3.4. Determination of immobilized α-lipoic acid stability
The stability of immobilized ALA was determined by storing the
membranes in pH 7.4 PBS at 37 1C for a period of 4 h. The retained
antioxidant activities of the two membranes, PEI–ALA-I and PEI–
ALA-III, are similar (Fig. 8) since they include almost the same
amount of ALA at the end of storage period in PBS. The resistances
of the membranes to sterilization conditions were also evaluated by
measuring their radical scavenging activities after treatment with
ethyleneoxide. The results demonstrated that the activity of ALA
immobilized on PEI–ALA-I and PEI–ALA-II membranes decreased by
27% and 19%, respectively. Immobilization of ALA between two PEI
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Table 2
The ratio of calculated peak areas of the PEI–ALA-I membrane to those of PEI–ALA-
II membrane.
Main peaks N1s S2p
Deconvoluted peaks –NH3þ –S–C or –S–H –S–S –S–O
Core level (eV) 400.7 162.7 164.1 167.1
Takeoff angle (deg)
15 0.93 1.88 2.84 0.97
75 0.85 1.34 1.51 1.04
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layers caused less activity loss during sterilization and storage in
PBS compared to the case that ALA was on the outermost layer of
the assembly.
3.5. Protein adsorption capacity of PSF membranes
The amount of plasma protein adsorbed on the membranes
was determined since this is the key phenomenon of hemocom-
patibility. The highest plasma protein adsorption occured on most
hydrophobic PSF membranes, whereas blending PSF with SPSF and
coating this blend membrane with PEI–ALA layer reduced protein
adsorption by 24% and approximately 40%, respectively, as seen in
Fig. 9. Although the PSF membrane has the smoothest surface, less
protein binding to the PSF–SPSF and PEI–ALA deposited mem-
branes is related to their more hydrophilic character. In addition,
the blend membrane, PSF–SPSF, and the ALA immobilized mem-
branes, PEI–ALA-I and PEI–ALA-III, carry negatively charged groups
on their surfaces that can repel similarly charged blood proteins.
The PEI/ALA or PEI/ALA/PEI coated membranes adsorb less protein
than the PSF–SPSF membrane since their surfaces are much more
smooth.
3.6. Platelet adhesion and activation
Platelet activation on different membranes was determined
because they play a crucial role in coagulation by secreting or
releasing prothrombotic factors. Fig. 10 shows that the highest
platelet activation occurred on the PSF and PSF–SPSF membranes,
on the other hand, ALA immobilization remarkably decreased the
activation (po0.05). The suppression of platelet activation on the
modified membranes can be attributed to their lower protein
adsorption capacities since the activation of intrinsic coagulation,
platelet adhesion and aggregation may depend on the composition
and conformation of the protein layer adsorbed onto the surface.
The differences in the platelet activation on the PEI–ALA deposited
membranes were found insignificant (p40.05)
The morphology and activation of adhered platelet on the
uncoated and coated surfaces after incubation with PRP were also
examined by SEM analysis. Fig. 11 shows that numerous adhered
platelets were observed on the SPSF–PSF blend membrane com-
pared with those on the PEI–ALA coated membranes. The mor-
phology of adhered platelets can be used as an indication of the
platelet activation. As can be seen from Fig. 11, platelets on the
surface of the SPSF–PSF membrane lost the discoid shape indicat-
ing the beginning of the activation. ALA immobilization prevents
the platelet activation not only by reducing the protein adsorption
capacity of the membranes but also by inhibiting the ROS
production in blood. In a clinical study by Chang et al. [14] ALA
administration in end-stage renal disease patients reduced the
asymmetric dimethylargigine (ADMA) level in blood, which is
indicative of decreased platelet aggregation [14].
3.7. Activated partial thromboplastin time (APTT)
All ALA immobilized membranes displayed significantly longer
APTT values than the PSF, PSF–SPSF membranes and the control
(Table 3). This can be explained by decreased adsorption of blood
proteins and platelet activation on these mebranes. In addition, as
Fig. 6. AFM images of (a) PSF, (b) PSF–SPSF and (c) PEI–ALA-I, (d) PEI–ALA-II membranes.
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will be discussed in the next section, the production of ROS is
suppressed when blood is in contact with ALA deposited mem-
branes, which helps to prolong the APTT through inhibition of
intrinsic pathway. The results in Table 3 suggest that the ALA
immobilization on the PSF membrane may allow to decrease the
amount of anticoagulant injected to the patient during
hemodialysis.
3.8. Inhibition of reactive oxidant species in plasma
The ability of uncoated and coated membranes in the inhibition
of ROS in whole blood is shown in Fig. 12 where the ROS level was
expressed as CL counts of HOCl. The results show that the ALA
immobilized on the SPSF–PSF membrane significantly suppressed
the ROS formation in blood. The difference in the CL counts of
HOCl obtained with the ALA loaded membranes and the control
(blood incubated without any membrane) was found statisti-
cally insignificant (p40.05). Clinical studies showed that admin-
istration of ALA could decrease the biomarkers of hemodialysis
induced oxidative stress in end-stage renal disease patients [14].
ALA is possibly rapidly converted to DHLA in many tissues after
administrated. ALA and its reduced form DHLA redox couple
effectively scavenge a number of free radicals, such as H2O2, HOCl,
and O2 in both lipid and aqueous domains. On the other hand,
other antioxidants used to modify hemodialysis membranes in
previous studies are effective either in aqueous medium (vitamin
C) or lipid environment (vitamin E). It has been noted that ALA is
one of the most powerful antioxidant and also prooxidant for the
other antioxidants in blood. The prooxidative property of ALA has
been shown in studies (in vitro and in vivo) by regeneration of
variety antioxidants including glutathione, vitamin C, vitamin E
and coenzyme Q10 [13].
3.9. Cytotoxicity of PSF membranes
A functional agent intended for biomedical applications should
be nontoxic in its pure form. In this study, the cytotoxicity of pure
ALA was not measured since it is administrated to hemodialysis
patients to reduce complications caused by oxidative stress.
As pointed out earlier, the maximum amount of ALA released
from the membranes is lower than the amount orally taken by the
hemodialysis patients. Cytotoxicity studies conducted with the
membranes have shown that the viability of peripheral
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mononuclear blood cells (PMBC) after 4 h treatment with unmo-
dified and modified membranes is close to 100% (Table 4). The
excellent cell viability of the modified membranes confirms that
the immobilization method proposed in this study does not have a
significant negative effect on the nontoxic property of the unmo-
dified PSF membrane.
3.10. Permeation of solutes through unmodified and modified
PSF–SPSF membranes
To illustrate the influence of ALA immobilization on the transport
properties of PSF membranes, permeation experiments were per-
formed with the uncoated and two coated membranes. Urea
(MW¼60 g mol1), vitamin B12 (MW¼1700 gmol1) and lysozyme
(MW¼14,600 gmol1) were choosen in order to simulate different
sized solutes in blood. Fig. 13 shows that the permeation coefficients
decrease exponentially with the increased molecular weight of the
solutes as expected. The difference in the transport characteristics of
SPSF-PSF PEI-ALA-I
PEI-ALA-II PEI-ALA-III
Fig. 11. The SEM pictures of unmodified and modified PSF membranes after incubating with PRP for 25 min, magnification 2000 .
Table 3
The APTT values for modified and unmodified PSF
membranes.
Sample APTT (s)
Control 3972
PSF 3773
PSF–SPSF 3873
PEI–ALA-I 6175
PEI–ALA-II 5772
PEI–ALA-III 6477
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Fig. 12. The inhibition HOCl in blood by unmodified and modified membranes.
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ALA loaded membranes was found statistically insignificant (p40.05).
This was expected since only the surface of the membrane was
modified, bulk structure remained unchanged due to polyelectrolyte
deposition. Moreover, additional mass transfer resistance is rather
small since the increase in the total thickness due to PEI–ALA
deposition is negligible. The clearing performances of modified and
unmodified PSF membranes for middle molecular weight model
solutes lysozyme and vitamin B12 are comparable with the results
obtained with the industrial hemodialysis membranes AN69
(1.51012 m2 s1 for MW¼15,000; 4.01011 m2 s1 for MW¼
1700) and Cuprophan (1.01013 m2 s1 MW¼15,000; 1.5
1011 m2 s1 MW¼1700), reported by Langsdorf and Zydney [22].
In addition to model solutes, urea, vitamin B12 and lysozyme, the
permeation of bovine serum albumin (BSA) was also studied. The
results demonstrated that only 1–2% of the initial BSA can permeate
through unmodified and ALA immobilized membranes. This means
that the molecular weight cut-off values of the PSF membranes are
approximately the same as the molecular weight of BSA (66.5 kDa)
which is a required value for hemodialysis membranes to prevent loss
of albumin in blood.
4. Conclusion
In this study, immobilization of ALA onto PSF based hemodia-
lysis membranes is suggested to prevent hemodialysis induced
oxidative stress. The immobilization method used in this study
is novel in that it is based on site-specific binding of a carboxylic
group of ALA to an ammonium group of anchoring polyelectrolyte
layer-PEI-through electrostatic interactions. Consequently, the active
site of ALA becomes available on the surface of the membrane to
scavenge reactive oxygen species. This was demonstrated by the
antioxidant activity results where the immobilization of ALA onto the
PSF membrane prolonged its stability under typical hemodialysis
conditions. The highest antioxidant activity was obtained when ALA
was sandwiched between two PEI layers. In vitro studies showed that
ALA coated membranes are capable of reducing ROS levels in blood,
protein adsorption and the platelet activation on the membranes.
Furthermore, they can significantly prolong the APTT values without
altering permeation rates. The antifouling and antioxidant properties
of the membranes prepared with 1 and 5 mg.mL-1 ALA are not
significantly different; therefore, it is suggested to use the lower
concentration during preparation. Based on the results it is fair to
conclude that an ALA-immobilized PSF membrane could be an
alternative membrane for preventing hemodialysis induced oxidative
stress and may allow decreasing the amount of anticoagulant
injected to the patient during hemodialysis.
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